Inari Medical, Inc.
NARIDelisted Feb 19, 2025- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001531048
Inari Medical, Inc. was delisted on Feb 19, 2025; its insiders filed their last Form 4 on Feb 19, 2025; 258 institutions reported holding it in 13F filings for Q4 2024, worth $2.80B in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Inari Medical, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Inari Medical, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Mead Dana G Jr. | Director | 0 | Feb 19, 2025 | 0 |
| Root Jonathan D | Director | 0Indirect | Feb 19, 2025 | 0 |
| Milder Donald B | Director | 0Indirect | Feb 19, 2025 | 0 |
| Hoffman William | Director | 0 | Feb 19, 2025 | 0 |
| Lucchese Cynthia L | Director | 0 | Feb 19, 2025 | 0 |
| Szyman Catherine M. | Director | 0 | Feb 19, 2025 | 0 |
| Tu Thomas | Chief Medical Officer | 0 | Feb 19, 2025 | 0 |
| Hykes Andrew | President and CEO | 0 | Feb 19, 2025 | 0 |
| Chambers Rebecca | Director | 0 | Feb 19, 2025 | 0 |
| Warner Robert Keith | Director | 0 | Feb 19, 2025 | 0 |
| Strange Kevin T | Chief Financial Officer | 0 | Feb 19, 2025 | 0 |
| Silva Karen | Principal Accounting Officer | 0 | Feb 19, 2025 | 0 |
| Hill, Mitch C. | Chief Financial Officer | 177,533 | Oct 2, 2024 | 0 |
| Nielsen Kirk G. | Director | 61,479 | May 30, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 31, 2024 (view filing) | Oct 29 | 2 days | Hoffman WilliamDirector | SSale | −40.0K | $50.05 | −$2.00M | −6.7%561.2K after | 2 lots10b5-1 |
| Oct 31, 2024 (view filing) | Oct 29 | 2 days | Hykes AndrewPresident and CEO | SSale | −3.00K | $50.00 | −$150.0K | −0.7%445.3K after | 10b5-1 |
| Nov 20, 2024 (view filing) | Nov 18 | 2 days | Hoffman WilliamDirector | SSale | −60.0K | $51.16 | −$3.07M | −10.7%501.2K after | 5 lots10b5-1 |
| Nov 22, 2024 (view filing) | Nov 20 | 2 days | Hykes AndrewPresident and CEO | SSale | −3.00K | $50.83 | −$152.5K | −0.7%442.3K after | 10b5-1 |
| Dec 12, 2024 (view filing) | Dec 10 | 2 days | Tu ThomasChief Medical Officer | SSale | −4.00K | $55.00 | −$220.0K | −1.3%304.0K after | 10b5-1 |
| Dec 18, 2024 (view filing) | Dec 16 | 2 days | Hoffman WilliamDirector | SSale | −60.0K | $55.66 | −$3.34M | −12.0%441.2K after | 8 lots10b5-1 |
| Dec 20, 2024 (view filing) | Dec 20 | Same day | Hykes AndrewPresident and CEO | SSale | −3.00K | $55.29 | −$165.9K | −0.7%439.3K after | 2 lots10b5-1 |
| Jan 8, 2025 (view filing) | Jan 6 | 2 days | Hoffman WilliamDirector | SSale | −200.0K | $60.47 | −$12.1M | −45.6%239.0K after | 2 lots10b5-1 |